A Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Affective Disorder

NCT00593099 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

5

Enrollment

NIH

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: Bupropion
DRUG: Placebo

Sponsor

National Institute on Drug Abuse (NIDA)